2027 Medicare enrollment opens with new drug caps and eligibility rules
The 2027 Medicare open enrollment period runs until Dec. 7, featuring price caps on GLP-1 drugs, updated plan-comparison tools and tighter immigrant eligibility.
Medicare’s annual enrollment season, which began on Oct. 15 and ends on Dec. 7, allows seniors and other eligible individuals to reassess their health coverage. The 2027 cycle introduces negotiated price caps for high-cost GLP-1 drugs, reducing out-of-pocket expenses for those medications. The Plan Finder tool now displays expanded information on supplemental benefits and network details, helping users compare options more thoroughly.
Health-policy analyst Louise Norris recommends confirming that prescribed drugs remain covered and that preferred doctors stay in-network. The administration also announced stricter rules for immigrant enrollment, limiting eligibility to legal permanent residents and citizens of Cuba, Haiti, and certain Pacific islands. Beneficiaries are urged to avoid scams by using official Medicare channels.
Why it matters
Changes affect millions of Medicare users' drug costs, plan choices and eligibility, impacting their health expenses and access.
How the sides frame it
LOW AGREEMENTLeft-leaning coverage highlights new drug price caps, stricter immigrant eligibility rules and consumer advice, while centrist coverage stresses the large number of beneficiaries forced to find new plans because insurers are ending coverage.
LEFT
Focuses on policy changes that lower drug costs and tighten enrollment eligibility, urging beneficiaries to verify coverage and avoid scams.
CENTER
Focuses on the disruption to millions of enrollees as insurers cut plans, urging beneficiaries to review their options during the enrollment window.
The left emphasises
- negotiated price caps for high-cost GLP-1 drugs, reducing out-of-pocket expenses
- stricter rules for immigrant enrollment, limiting eligibility to legal permanent residents and citizens of Cuba, Haiti, and certain Pacific islands
- beneficiaries are urged to avoid scams
In this story
